Q-Cell is a high quality, well-characterised panel of primary brain cancer cell line models for academic and commercial use.

Q-Cell models have been extensively published in over 40 scientific journals including Cancer Cell, Nature Neuroscience, Acta Neuropathologica and Neuro-Oncology.

Q-Cell patient-derived glioblastoma (GBM) cell lines are cultured to maintain genetic and epigenetic stability with enhanced tumourigenic potential in vivo. All models form intracranial xenograft tumours and can be obtained transduced with a luciferase expressing construct for in vivo bioluminescent tumour tracking. 

Academic use: No restrictions are placed on Q-Cell models for academic use and can be obtained under an approved Material Transfer Agreement (MTA) from QIMR Berghofer. Please provide contact information including primary contact details for the MTA, shipping address, phone number and a 50-word paragraph outlining the proposed project.

Send to q-cell.glioma@qimrberghofer.edu.au or Bryan.Day@qimrberghofer.edu.au. Please note you will be required to cover the cost of cell line shipping. We also request that Professor Bryan Day and Dr Brett Stringer are included as authors on any academic publications arising from the use of Q-Cell models.

Commercial use: Q-Cell models are available for commercial “for profit” use and can be accessed under a license agreement from QIMR Berghofer. Please contact Professor Bryan Day at Bryan.Day@qimrberghofer.edu.au Phone: +61 7 3845 3885 for further details and to initiate an agreement.

Dr Brett Stringer MBBS PhD
Brain Cancer Research Fellow, Flinders University

Professor Bryan Day PhD
Group Leader, Sid Faithfull Brain Cancer Laboratory, QIMR Berghofer
T +61 7 3845 3885
E bryan.day@qimrberghofer.edu.au